Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Koenraad d'Hollander"'
Autor:
Corinne Jamoul, Laurence Collette, Elisabeth Coart, Koenraad D’Hollander, Tomasz Burzykowski, Everardo D. Saad, Marc Buyse
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Missing data may lead to loss of statistical power and introduce bias in clinical trials. The Covid-19 pandemic has had a profound impact on patient health care and on the conduct of cancer clinical trials. Although several endpoi
Externí odkaz:
https://doaj.org/article/de73c70f1fb345dbb3320e5b12c3a082
Autor:
Ruben Mesa, Stephen T. Oh, Aaron T. Gerds, Vikas Gupta, John Catalano, Francisco Cervantes, Timothy Devos, Marek Hus, Jean-Jacques Kiladjian, Ewa Lech-Maranda, Donal McLornan, Jeanne Palmer, Uwe Platzbecker, Jacek Treliński, Kazuya Shimoda, Rafe Donahue, Koenraad D’Hollander, Mark Kowalski, Srdan Verstovsek
Publikováno v:
Leukemia & Lymphoma. 63:1718-1722
ispartof: LEUKEMIA & LYMPHOMA vol:63 issue:7 pages:1718-1722 ispartof: location:United States status: published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e377f9b755aa157ae42ff1b8d18948
https://doi.org/10.1080/10428194.2022.2043304
https://doi.org/10.1080/10428194.2022.2043304
Autor:
Michael L Schilsky, Anna Czlonkowska, Massimo Zuin, David Cassiman, Carlos Twardowschy, Aurelia Poujois, Francisco de Assis A Gondim, Gerald Denk, Rubens G Cury, Peter Ott, Joanna Moore, Aftab Ala, Renata D'Inca, Eduardo Couchonnal-Bedoya, Koenraad D'Hollander, Nicolas Dubois, C Omar F Kamlin, Karl Heinz Weiss, Uyen To, Amar Patel, Daksshi Hettiarachchi, Alessia Giorgini, Sara Monico, Tomasz Litwin, Agnieszka Piechal, Marta Skowronska, Alain Lachaux, Abdelouahed Belmalih, Alexandra Boogers, Isabelle Mohr, Andrea Langel, Christian Freitas, Egberto Reis Barbosa, Thomas D Sandahl, Lisbet Gerdes, Alexandre Obadia, Djamila Rahli, Jeremy Cosgrove
Publikováno v:
CHELATE trial investigators 2022, ' Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE) : a randomised, open-label, non-inferiority, phase 3 trial ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 12, pp. 1092-1102 . https://doi.org/10.1016/S2468-1253(22)00270-9
Background: Wilson disease is an inherited disorder of copper transport. Whereas penicillamine is used therapeutically to re-establish copper balance, trientine is indicated for patients with penicillamine intolerance. We aimed to compare penicillami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc08a6d996987fd1d2dba0c63b14f359
https://pure.au.dk/portal/da/publications/trientine-tetrahydrochloride-versus-penicillamine-for-maintenance-therapy-in-wilson-disease-chelate(ba317b8b-40a9-4b06-9881-6e93f059c2ea).html
https://pure.au.dk/portal/da/publications/trientine-tetrahydrochloride-versus-penicillamine-for-maintenance-therapy-in-wilson-disease-chelate(ba317b8b-40a9-4b06-9881-6e93f059c2ea).html
Autor:
C.Oma Kamlin, Michael Schilsky, Peter Ott, Karl Heinz Weiss, Massimo Giovanni Zuin, Aurelia Poujois, Aftab Ala, Koenraad D’Hollander
Publikováno v:
Journal of Hepatology. 77:S539
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cb7b7e2420ee61249d88f278a5860e5
https://doi.org/10.1016/s0168-8278(22)01402-7
https://doi.org/10.1016/s0168-8278(22)01402-7
Autor:
Ruben A. Mesa, Miklos Egyed, Rafe Donahue, Jean-Jacques Kiladjian, Donal P. McLornan, Stephen T. Oh, John Catalano, Koenraad d'Hollander, Kazuya Shimoda, Mark Kowalski, Elisabeth Coart, Francisco Cervantes, Jason Gotlib, Timothy Devos
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S329-S330
Background: Systemic inflammation integral to the pathogenesis of myelofibrosis (MF) leads to increased ACVR1 activity and hepcidin production, resulting in perturbed iron homeostasis and iron-restricted anemia. Chronic, progressive anemia is a key h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cfeea1ef51a8bfded4b949660e47a39
https://doi.org/10.1016/s2152-2650(20)30991-5
https://doi.org/10.1016/s2152-2650(20)30991-5
Autor:
Volkmar Mueller, M. Maestro, Denise M. Wolf, Justin Stebbing, Karsten Weber, Paul Blanche, Masakazu Toi, Antonio Llombart-Cussac, Alessandra Meddis, Andreas D. Hartkopf, Jun Horiguchi, Fabien Reyal, Randi R. Mathiesen, Olav Engebraaten, Charlotte Proudhon, Laura J. Esserman, Paul Cottu, Rafael Gisbert-Criado, José A. García-Sáenz, Patrice Viens, Koenraad d'Hollander, Sara Y. Brucker, François-Clément Bidard, Maria Rosa Cappelletti, Elin Borgen, John W. Park, Dominic Amara, Daisuke Takata, Klaus Pantel, Vicente Carañana, Jaco Kraan, Jessica B. Bowman Bauldry, Stefan Michiels, Noriyoshi Fujisawa, Eduardo Díaz-Rubio, Jose Vidal-Martinez, Hideaki Tokiniwa, Françoise Rothé, Bjørn Naume, Stefan Sleijfer, Anthony Lucci, Mandar Karhade, Aurélien Latouche, Michail Ignatiadis, Carolyn S. Hall, Sibylle Loibl, Florin-Andrei Taran, Daniele Generali, Jean-Yves Pierga, Sabine Riethdorf, Jeffrey B. Smerage, Wendy Onstenk, Rin Nagaoka, Laura Muinelo-Romay, Mark Jesus M. Magbanua
Publikováno v:
Journal of the National Cancer Institute, 110(6):djy018, 560-567. Oxford University Press
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
Consejo Superior de Investigaciones Científicas (CSIC)
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
Consejo Superior de Investigaciones Científicas (CSIC)
Background: We conducted a meta-analysis in nonmetastatic breast cancer patients treated by neoadjuvant chemotherapy (NCT) to assess the clinical validity of circulating tumor cell (CTC) detection as a prognostic marker. Methods: We collected individ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7081fc5de0490a8b10de50cb8818794e
https://pure.eur.nl/en/publications/34dfe697-929d-471e-9878-18ec73f848c6
https://pure.eur.nl/en/publications/34dfe697-929d-471e-9878-18ec73f848c6
Autor:
Ruben A Mesa, John Catalano, Francisco Cervantes, Timothy Devos, Jason Gotlib, Jean-Jacques Kiladjian, Donal P. McLornan, Kazuya Shimoda, Elisabeth Coart, Koenraad D'Hollander, Rafe Donahue, Mark M Kowalski
Publikováno v:
Blood. 134:1663-1663
Momelotinib (MMB) is a potent, selective, orally-bioavailable, small-molecule inhibitor of JAK1, JAK2 and ACVR1 being developed for the treatment of intermediate and high risk myelofibrosis (MF). Systemic inflammation integral to the pathogenesis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86ba423d3844f0e78b562b9db295c722
https://doi.org/10.1182/blood-2019-122506
https://doi.org/10.1182/blood-2019-122506
Autor:
JA Garcia-Saenz, Fabien Reyal, Patrice Viens, Denise M. Wolf, Jun Horiguchi, Stefan Michiels, Wendy Onstenk, F-C Bidard, F-A Taran, John W. Park, Koenraad d'Hollander, Noriyoshi Fujisawa, Jose Vidal-Martinez, L Muinelo, Hideaki Tokiniwa, Klaus Pantel, Anthony Lucci, N Name, Jeffrey B. Smerage, Justin Stebbing, Carolyn S. Hall, Jaco Kraan, S Riethdorf, Eduardo Díaz-Rubio, Rin Nagaoka, Rafael Gisbert-Criado, Antonio Llombart-Cussac, Michail Ignatiadis, J-Y Pierga, Sara Y. Brucker, B Naume, F Rothe, Sibylle Loibl, Charlotte Proudhon, Elin Borgen, M. Maestro, O Engebråtenm, M Toi, Vicente Carañana, M Gopalkrishna Karhade, Cappelletti, R Ruud Mathiesen, A Hartkopf, Dominic Amara, Daisuke Takata, D Generali, V Mueller, LJ Esserman, M Magbanua, J Bowman Bauldry, K Weber, S Sleijfer, Paul Cottu
Publikováno v:
Cancer Research. 77:S3-01
Background We performed an international meta-analysis of individual patient data to assess the clinical validity of circulating tumor cell (CTC) count in non-metastatic breast cancer (BC) patients (pts) treated by neoadjuvant chemotherapy (NCT). Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c597fd2c240aaae656cb00b21902dde
https://doi.org/10.1158/1538-7445.sabcs16-s3-01
https://doi.org/10.1158/1538-7445.sabcs16-s3-01